Marketing-authorisation holder · Italy
Chiesi Farmaceutici S.P.A.
89 medicines in 4 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Italy
89 medicines in 4 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 89
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ASALEXCompressa a rilascio modificato | Mesalazine | Italy | Authorised | |
| ATIMOSSoluzione pressurizzata per inalazione | Formoterol | Italy | Authorised | |
| BRAMITOBSoluzione per nebulizzatore | Tobramycin | Italy | Authorised | |
| BUDIAIRSoluzione pressurizzata per inalazione | Budesonide | Italy | Authorised | |
| CLENILSoluzione pressurizzata per inalazione | Beclometasone | Italy | Authorised | |
| CLEVIPREXEmulsione iniettabile | Clevidipine | Italy | Authorised | |
| CLEVIPREX0.5 mg / ml · Emulsion | Clevidipine | Canada | Marketed | 2023 |
| CLIPPERCompressa gastroresistente | Beclometasone | Italy | Authorised | |
| CUROSURFSospensione per instillazione endotracheobronchiale | Natural phospholipids | Italy | Authorised | |
| CUROSURF80 mg / ml · Suspension | Natural phospholipids | Canada | Marketed | 2016 |
| ELFABRIOConcentrato per soluzione per infusione | Pegunigalsidase alfa | Italy | Authorised | |
| ELFABRIO20 mg / 10 ml · Solution | Pegunigalsidase alfa | Canada | Marketed | 2026 |
| Elfabrio | Pegunigalsidase alfa | EU (EMA) | Authorised | 2023 |
| ELFABRIO5 mg / 2.5 ml · Solution | Pegunigalsidase alfa | Canada | Marketed | 2026 |
| ELFABRIO 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION20 mg · Concentrado para solución para perfusión | Pegunigalsidase alfa | Spain | Marketed | 2023 |
| ENVARSUSCompressa a rilascio prolungato | Tacrolimus | Italy | Authorised | |
| Envarsus | Tacrolimus | EU (EMA) | Authorised | 2014 |
| Envarsus 0,75mg comprimidos de liberacion prolongada0,765 mg · Comprimido de liberación modificada | Tacrolimus | Spain | Marketed | 2015 |
| Envarsus 1mg comprimidos de liberacion prolongada1,02 mg · Comprimido de liberación modificada | Tacrolimus | Spain | Marketed | 2015 |
| Envarsus 1mg comprimidos de liberacion prolongada1,02 mg · Comprimido de liberación modificada | Tacrolimus | Spain | Marketed | 2015 |
| Envarsus 4mg comprimidos de liberacion prolongada4,08 mg · Comprimido de liberación modificada | Tacrolimus | Spain | Marketed | 2015 |
| EUCHESSINA C.M.Compressa masticabile | Picosolfato | Italy | Authorised | |
| FERRIPROXCompressa rivestita con film | Deferiprone | Italy | Authorised | |
| Ferriprox | Deferiprone | EU (EMA) | Authorised | 1999 |
| FERRIPROX 100 MG/ML SOLUCION ORAL100 mg · Solución oral | Deferiprone | Spain | Marketed | 2010 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Italy | 32 | 32 | 0 | CompaniesAll medicines |
| Spain | 27 | 27 | 0 | CompaniesAll medicines |
| Canada | 15 | 14 | 1 | CompaniesAll medicines |
| European Union (EMA) | 15 | 14 | 1 | CompaniesAll medicines |
Also in the registers of Brazil, Croatia, Netherlands, Romania, Serbia, Singapore, United States
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
AIFA; Gazzetta Ufficiale della Repubblica Italiana. Exact act IDs, publication dates, locators, URLs and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: Official administrative act text exclusion, Italian Law633/1941 Article5
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.